Crossmark

Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia

Crossref DOI link: https://doi.org/10.1038/s41598-019-55830-3

Published Online: 2019-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yedlapudi, Deepthi https://orcid.org/0000-0002-9811-8976
Xu, Liping

Luo, Dan

Marsh, Gregory B.

Todi, Sokol V.

Dutta, Aloke K.
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS047198)
License Information

Text and Data Mining valid from 2019-12-23

Version of Record valid from 2019-12-23
More Information

Article History

Received: 4 March 2019

Accepted: 28 November 2019

First Online: 23 December 2019

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below